The Healthcare Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar.

Investing in Halozyme Therapeutics is a compelling way to gain exposure to the broader healthcare and biotechnology industries.Over the last three months, the S&P 500 healthcare sector has risen 13%, compared to the broader S&P 500 index's 7% increase. However, one stock that hasn't matched its sector's returns is Halozyme Therapeutics (HALO +0.60%). Down 9% over the last few months, here's why Halozyme is a great buy right now.NASDAQ : HALOHalozyme TherapeuticsToday's Change( 0.60 %) $ 0.38Current Price$ 6 ...